Abstract
Transdermal iontophoresis enables hydrophilic, charged, or neutral molecules to be administered through the skin in an effective, noninvasive, patient-friendly manner. This chapter presents the basic concepts, mechanisms, and an analysis of electrotransport across the skin as a function of (i) electrical parameters, such as current density; (ii) formulation parameters, such as the influence of drug concentration, pH, and the presence of competing ions; and (iii) the delivery system.
References
Abla N, Naik A, Guy RH, Kalia YN (2005) Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. J Control Release 108:319ā330
Aguilella V, Kontturi K, Murtomaki L, Ramirez P (1994) Estimation of the pore-size and charge-density in human cadaver skin. J Control Release 32:249ā257
Alvarez-Figueroa MJ, Blanco-Mendez J (2001) Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 215:57ā65
Banga AK, Chien YW (1993) Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs. Pharm Res 10:697ā702
Burnette RR, Marrero D (1986) Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci 75:738ā743
Cazares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, Lopez-Castellano AC, Merino V, Kalia YN (2010) Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies. Eur J Pharm Sci 39:387ā393
Che X, Wang LH, Yuan Y, Gao YN, Wang QF, Yang Y et al (2012) A novel method to enhance the efficiency of drug transdermal iontophoresis delivery by using complexes of drug and ion-exchange fibers. Int J Pharm 428:68ā75
Craanevanhinsberg WHM, Bax L, Flinterman NHM, Verhoef J, Junginger HE, Bodde HE (1994) Iontophoresis of a model peptide across human skin in-vitro. Effects of iontophoresis protocol, pH, and ionic-strength on peptide flux and skin impedance. Pharm Res 11:1296ā1300
Cullander C, Guy RH (1991) Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J Invest Dermatol 97:55ā64
de Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S (2001) Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers. J Control Release 75:191ā197
Delgado-Charro MB, Guy RH (1994) Characterization of convective solvent flow during iontophoresis. Pharm Res 11:929ā935
Delgado-Charro MB, Guy RH (1995) Iontophoretic delivery of nafarelin across the skin. Int J Pharm 117:165ā172
Delgado-Charro MB, Guy RH (2001) Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. Stp Pharma Sci 11:403ā414
Delgado-Charro MB, Rodriguezbayon AM, Guy RH (1995) Iontophoresis of nafarelin ā effects of current-density and concentration on electrotransport in-vitro. J Control Release 35:35ā40
Djabri A, Guy RH, Delgado-Charro MB (2012a) Transdermal iontophoresis of ranitidine: an opportunity in paediatric drug therapy. Int J Pharm 435:27ā32a
Djabri A, Guy RH, Delgado-Charro MB (2012b) Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy. Int J Pharm 435:76ā82b
Fallows SJ, Garland MJ, Cassidy CM, Tunney MM, Singh TRR, Donnelly RF (2012) Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy. J Photochem Photobiol B-Biol 114:61ā72
Fang JY, Hsu LR, Huang YB, Tsai YH (1999) Evaluation of transdermal iontophoresis of enoxacin from polymer formulations: in vitro skin permeation and in vivo microdialysis using Wistar rat as an animal model. Int J Pharm 180:137ā149
Fang JY, Sung KC, Hu OYP, Chen HY (2001) Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis. Drug Res 51:408ā413
Fang JY, Sung KC, Wang JJ, Chu CC, Chen KT (2002) The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels. J Pharm Pharmacol 54:1329ā1337
Gratieri T, Kalia YN (2013) Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. Adv Drug Deliv Rev 65:315ā329
Green P, Shroot B, Bernerd F, Pilgrim WR, Guy RH (1992) In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J Control Release 20:209ā218
Haak RP, Gyory JR, Theeuwes F, Landrau FA, Roth N, Meyers RM (1994) Iontophoretic delivery device and methods of hydrating same. US5320598
Hirvonen J, Guy RH (1997) Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances. Pharm Res 14:1258ā1263
Hirvonen J, Kalia YN, Guy RH (1996) Transdermal delivery of peptides by iontophoresis. Nat Biotechnol 14:1710ā1713
Hoogstraate AJ, Srinivasan V, Sims SM, Higuchi WI (1994) Iontophoretic enhancement of peptides ā behavior of leuprolide versus model permeants. J Control Release 31:41ā47
Jadoul A, Bouwstra J, Preat V (1999) Effects of iontophoresis and electroporation on the stratum corneum ā review of the biophysical studies. Adv Drug Deliv Rev 35:89ā105
Jyoung JY, Shim BS, Cho DE, Hwang IS (2009) Iontophoretic transdermal delivery of alendronate in hairless mouse skin. Polymer-Korea 33:237ā242
Kalaria DR, Patel P, Patravale V, Kalia YN (2012) Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro. Int J Pharm 438:202ā208
Kalia YN, Naik A, Garrison J, Guy RH (2004) Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619ā658
Kasting GB (1992) Theoretical-models for iontophoretic delivery. Adv Drug Del Rev 9:177ā199
Kasting GB, Keister JC (1989) Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J Control Release 8:195ā210
Lau DT, Sharkey JW, Petryk L, Mancuso FA, Yu Z, Tse FL (1994) Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin) in the rabbit. Pharm Res 11:1742ā1746
Levin J, Maibach H (2008) Human skin buffering capacity: an overview. Skin Res Technol 14:121ā126
Lu MF, Lee D, Carlson R, Rao GS, Hui HW, Adjei L et al (1993) The effects of formulation variables on iontophoretic transdermal delivery of leuprolide to humans. Drug Dev Ind Pharm 19:1557ā1571
Marro D, Guy RH, Delgado-Charro MB (2001a) Characterization of the iontophoretic permselectivity properties of human and pig skin. J Control Release 70:213ā7a
Marro D, Kalia YN, Delgado-Charro MB, Guy RH (2001b) Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 18:1701ā8b
Merclin N, Bramer T, Edsman K (2004) Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle. J Control Release 98:57ā65
Morrel EM, Spruance SL, Goldberg DI (2006) Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial. Clin Infect Dis 43:460ā467
Mudry B, Guy RH, Begona Delgado-Charro M (2006a) Prediction of iontophoretic transport across the skin. J Control Release 111:362ā7a
Mudry B, Guy RH, Delgado-Charro MB (2006b) Transport numbers in transdermal iontophoresis. Biophys J 90:2822ā30b
Mudry B, Guy RH, Delgado-Charro MB (2006c) Electromigration of ions across the skin: determination and prediction of transport numbers. J Pharm Sci 95:561ā9c
Nair V, Panchagnula R (2003) Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. Pharm Res 48:175ā182
Padula C, Sartori F, Marra F, Santi P (2005) The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm Res 22:1519ā1524
Panzade P, Heda A, Puranik P, Patni M, Mogal V (2012) Enhanced transdermal delivery of granisetron by using iontophoresis. Iran J Pharm Res 11:503ā512
Patel SR, Zhong H, Sharma A, Kalia YN (2007) In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Eur J Pharm Biopharm 66:296ā301
Patel SR, Zhong H, Sharma A, Kalia YN (2009) Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Eur J Pharm Biopharm 72:304ā309
Phipps JB, Gyory JR (1992) Transdermal ion migration. Adv Drug Deliv Rev 9:137ā176
Phipps JB, Padmanabhan RV, Lattin GA (1989) Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 78:365ā369
Pikal MJ (1990) Transport Mechanisms in Iontophoresis. 1. A theoretical-model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 7:118ā126
Pikal MJ (1992) The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 9:201ā237
Pikal MJ (2001) The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 46:281ā305
Rodriguez Bayon AM, Guy RH (1996) Iontophoresis of nafarelin across human skin in vitro. Pharm Res 13:798ā800
Sage BH, Riviere JE (1992) Model systems in iontophoresis transport efficacy. Adv Drug Deliv Rev 9:265ā287
Schuetz YB, Naik A, Guy RH, Vuaridel E, Kalia YN (2005) Transdermal iontophoretic delivery of triptorelin in vitro. J Pharm Sci 94:2175ā2182
Shukla C, Friden P, Juluru R, Stagni G (2009) In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. J Pharm Sci 98:917ā925
Siddoju S, Sachdeva V, Friden PM, Yu YY, Banga AK (2011) Acyclovir skin depot characterization following in vivo iontophoretic delivery. Skin Res Technol 17:234ā244
Srinivasan V, Higuchi WI (1990) A model for iontophoresis incorporating the effect of convective solvent flow. Int J Pharm 60:133ā138
Stagni G, Ali ME, Weng D (2004) Pharmacokinetics of acyclovir in rabbit skin after IV-bolus, ointment, and iontophoretic administrations. Int J Pharm 274:201ā211
Tatavarti AS, Mehta KA, Augsburger LL, Hoag SW (2004) Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J Pharm Sci 93:2319ā2331
Taveira SF, Nomizo A, Lopez RFV (2009) Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J Control Release 134:35ā40
Volpato NM, Santi P, Colombo P (1995) Iontophoresis enhances the transport of acyclovir through nude-mouse skin by electrorepulsion and electroosmosis. Pharm Res 12:1623ā1627
Volpato NM, Nicoli S, Laureri C, Colombo P, Santi P (1998) In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release 50:291ā296
Xu QF, Ibrahim SA, Higuchi WI, Li SK (2009) Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir. Int J Pharm 369:105ā113
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gratieri, T., Kalia, Y.N. (2017). Iontophoretic Transport Mechanisms and Factors Affecting Electrically Assisted Delivery. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53273-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-53273-7_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53271-3
Online ISBN: 978-3-662-53273-7
eBook Packages: MedicineMedicine (R0)